Deng Jie, Wang Xiaozeng, Shi Yana, Zhao Xin, Han Yaling
Department of Cardiology, The General Hospital of Shenyang Military Region, Chinese People's Liberation Army, Shenyang, China.
Department of Cardiology, Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
J Interv Cardiol. 2018 Feb;31(1):33-40. doi: 10.1111/joic.12448. Epub 2017 Sep 20.
It is not known if ACEF scores could evaluate the prognosis of recanalization of non-infarct-related coronary arteries (non-IRA) with chronic total occlusions (CTO) in patients who successfully underwent primary PCI. The objective of the current study was to assess the prognostic value of ACEF scores in acute ST-segment elevation myocardial infarction (STEMI) patients with non-IRA CTO after successful primary PCI.
There were 2952 STEMI patients who underwent successful primary PCI from January 2006 to December 2014 in our hospital, among them 377 patients had a non-IRA CTO lesion. The patients were divided into successful CTO-PCI group (n = 221) and failed/non-attempted CTO-PCI group (n = 156). Patients were stratified based on the ACEF tertiles. Primary end points measured in the current study were major adverse cardiac events (MACE) defined as the composite of all-cause death, nonfatal myocardial infarction, ischemia-driven coronary revascularization and hospitalization for heart failure at 1 year.
The incidence of MACE, all-cause death and cardiac death were higher in the failed/non-attempted CTO-PCI group (P < 0.001). In the successful CTO-PCI group, the cumulative 1-year incidences of MACE and all-cause death were decreased compared to those in the failed/non-attempted CTO-PCI group (log-rank P < 0.001). The risk for MACE was reduced in the successful CTO-PCI group compared to the failed/non-attempted CTO-PCI group in patients with low and intermediate ACEF scores (log-rank P = 0.02).
Successfully staged CTO-PCI could gain advantageous clinical outcomes in those patients with low or intermediate ACEF scores.
对于成功接受直接经皮冠状动脉介入治疗(PCI)的患者,急性冠状动脉事件频率(ACEF)评分能否评估慢性完全闭塞(CTO)的非梗死相关冠状动脉(非IRA)再通的预后尚不清楚。本研究的目的是评估ACEF评分在成功进行直接PCI后的急性ST段抬高型心肌梗死(STEMI)合并非IRA CTO患者中的预后价值。
2006年1月至2014年12月在我院成功进行直接PCI的2952例STEMI患者中,377例患者存在非IRA CTO病变。将患者分为CTO-PCI成功组(n = 221)和CTO-PCI失败/未尝试组(n = 156)。根据ACEF三分位数对患者进行分层。本研究测量的主要终点是主要不良心脏事件(MACE),定义为1年时全因死亡、非致命性心肌梗死、缺血驱动的冠状动脉血运重建和因心力衰竭住院的复合事件。
CTO-PCI失败/未尝试组的MACE、全因死亡和心源性死亡发生率更高(P < 0.001)。在CTO-PCI成功组中,与CTO-PCI失败/未尝试组相比,1年累积MACE和全因死亡发生率降低(对数秩P < 0.001)。在ACEF评分低和中等的患者中,CTO-PCI成功组的MACE风险低于CTO-PCI失败/未尝试组(对数秩P = 0.02)。
成功分期的CTO-PCI在ACEF评分低或中等的患者中可获得有利的临床结局。